Bvf Partners L P Five Prime Therapeutics, Inc. (FPRX) insider trading activity

FPRX Quotes by TradingView

Bvf Partners L P is of FIVE PRIME THERAPEUTICS, INC.. Currently has a direct ownership of 81,263 shares of FPRX, which is worth approximately $3.09 Million. The most recent transaction as insider was on Nov 11, 2020, when has been sold 7,393,340 shares (Common Stock, $0.001 par value) at a price of $20.19 per share, resulting in proceeds of $149,271,539. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.3K
0% 3M change
0% 12M change
Total Value Held $3.09 Million

BVF PARTNERS L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2020
SELL
Open market or private sale
$149,271,539 $20.19 p/Share
7,393,340 Reduced 98.91%
81,263 Common Stock, $0.001 p...
Nov 06 2020
BUY
Open market or private purchase
$149,400 $4.98 p/Share
30,000 Added 4.89%
583,912 Common Stock, $0.001 p...
Nov 04 2020
BUY
Open market or private purchase
$2,032,823 $4.88 p/Share
416,562 Added 41.73%
581,578 Common Stock, $0.001 p...
Oct 06 2020
BUY
Open market or private purchase
$1,740,015 $5.04 p/Share
345,241 Added 37.88%
566,223 Common Stock, $0.001 p...
Sep 22 2020
BUY
Open market or private purchase
$122 $3.8 p/Share
32 Added 0.01%
541,116 Common Stock, $0.001 p...
May 14 2020
BUY
Open market or private purchase
$1,203,707 $4.1 p/Share
293,587 Added 35.17%
541,084 Common Stock, $0.001 p...
Dec 20 2019
BUY
Open market or private purchase
$2,085,831 $4.05 p/Share
515,020 Added 48.97%
536,608 Common Stock, $0.001 p...
Dec 09 2019
BUY
Open market or private purchase
$542,700 $4.02 p/Share
135,000 Added 21.13%
504,002 Common Stock, $0.001 p...
Nov 22 2019
BUY
Open market or private purchase
$3,808,034 $3.4 p/Share
1,120,010 Added 69.07%
501,605 Common Stock, $0.001 p...
Nov 05 2019
BUY
Open market or private purchase
$3,872,448 $4.0 p/Share
968,112 Added 69.76%
419,748 Common Stock, $0.001 p...
Oct 31 2019
BUY
Open market or private purchase
$26,307 $3.85 p/Share
6,833 Added 1.92%
348,827 Common Stock, $0.001 p...
Oct 30 2019
BUY
Open market or private purchase
$78,115 $3.89 p/Share
20,081 Added 5.45%
348,323 Common Stock, $0.001 p...
Oct 29 2019
BUY
Open market or private purchase
$9,360 $3.9 p/Share
2,400 Added 0.69%
346,867 Common Stock, $0.001 p...
Oct 25 2019
BUY
Open market or private purchase
$115,432 $3.75 p/Share
30,782 Added 8.16%
346,627 Common Stock, $0.001 p...
Oct 24 2019
BUY
Open market or private purchase
$506,351 $3.74 p/Share
135,388 Added 28.21%
344,472 Common Stock, $0.001 p...
Oct 23 2019
BUY
Open market or private purchase
$12,000 $3.75 p/Share
3,200 Added 0.14%
2,355,186 Common Stock, $0.001 p...
Oct 08 2019
BUY
Open market or private purchase
$222,316 $3.68 p/Share
60,412 Added 14.98%
342,843 Common Stock, $0.001 p...
Oct 07 2019
BUY
Open market or private purchase
$1,969,012 $3.75 p/Share
525,070 Added 60.83%
338,154 Common Stock, $0.001 p...
Oct 04 2019
BUY
Open market or private purchase
$59,840 $3.74 p/Share
16,000 Added 5.07%
299,487 Common Stock, $0.001 p...

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CTIC
CTI BIOPHARMA CORP Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
> 10% Shareholder
ARQL
ARQULE INC
> 10% Shareholder
SNDX
Syndax Pharmaceuticals Inc Healthcare
> 10% Shareholder
XOMA
XOMA Corp Healthcare
Director
IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
> 10% Shareholder
CALA
Calithera Biosciences, Inc. Healthcare
> 10% Shareholder
CYTK
CYTOKINETICS INC Healthcare
MRUS
Merus N.V. Healthcare
> 10% Shareholder
IDYA
IDEAYA Biosciences, Inc. Healthcare
PRNB
Principia Biopharma Inc.
> 10% Shareholder
KYMR
Kymera Therapeutics, Inc. Healthcare
Director
OLMA
Olema Pharmaceuticals, Inc. Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
RAIN
Rain Therapeutics Inc. Healthcare
Director
RPTX
Repare Therapeutics Inc. Healthcare
> 10% Shareholder
CGEM
Cullinan Oncology, Inc. Healthcare
> 10% Shareholder
THRD
Third Harmonic Bio, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
> 10% Shareholder
MLTX
MoonLake Immunotherapeutics Healthcare
Director
PNT
POINT Biopharma Global Inc. Healthcare
FDMT
4D Molecular Therapeutics, Inc. Healthcare
BPL

Bvf Partners L P

San Francisco, CA

Track Institutional and Insider Activities on FPRX

Follow FIVE PRIME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FPRX shares.

Notify only if

Insider Trading

Get notified when an Five Prime Therapeutics, Inc. insider buys or sells FPRX shares.

Notify only if

News

Receive news related to FIVE PRIME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FPRX